Microbiome SIG Webinar Series
Our CEO, Dr. David Weinkove, explains how healthspan readouts can be used to understand mechanisms in the microbiome.
Microbiome SIG Webinar Series Read Post »
Magnitude Biosciences recognised in ‘Developed in Durham’ as local success story
Magnitude Biosciences has been recognised by Developed in Durham.
Magnitude Biosciences recognised in ‘Developed in Durham’ as local success story Read Post »
Magnitude Biosciences to attend Translating Ideas Into Therapies 2021 and the International C. elegans Conference in June 2021
June 2021 marks an exciting month as we see some of our C. elegans thought leaders speaking at key events.
A child, a worm, and a new era of drug discovery
This article will tell the story of how C. elegans enabled a life-changing effects drug therapy for a child suffering from a rare disease
A child, a worm, and a new era of drug discovery Read Post »
The worm angle on the taurine story: A route to the clinic by understanding mechanism
David Weinkove, 15 June 2023 A recent research article in Science showed that supplementing with taurine slows ageing across a number of
The worm angle on the taurine story: A route to the clinic by understanding mechanism Read Post »
Magnitude Biosciences secures its second round of funding to support its pre-clinical research services
To find out how Magnitude Biosciences can support your research contact us via info@magnitudebiosciences.com
